A pharmacokinetic and enzyme turnover model predicts major roles for cyp2b6 genotypes on the magnitude of efavirez autoinduction of metabolism and clearance in healthy volunteers.

Presented at ASCPT Annual Meeting 2024. A population PK and turnover models were developed and show that the extent of efavirenz autoinduction and clearance is dependent on CYP2B6 genotype.